LCI INDUSTRIES — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LCI INDUSTRIES filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.12B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.74B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.78B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $5.21B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $4.47B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.80B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $564.02M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $586.22M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $629.07M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $592.17M | Feb 27, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $980.30M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $879.72M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $776.19M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.27B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.04B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $706.09M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $122.48M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $135.47M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $148.65M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $132.59M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $188.25M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $142.87M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $64.20M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $394.97M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $287.74M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $158.44M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $28.81M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $35.81M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $47.53M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $34.37M | Feb 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $279.92M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $218.24M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $123.43M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $553.03M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $398.41M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $222.93M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $200.21M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $198.79M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $214.28M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $200.85M | Feb 27, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $495.31M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $465.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $453.33M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $720.26M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $644.63M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $483.16M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $338.99M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $321.56M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $278.83M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $228.05M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $330.98M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $370.28M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $527.23M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $602.51M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | ($111.57M) | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $231.40M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $269.53M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $156.61M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $152.70M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $201.67M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.64M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $42.33M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $62.21M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $130.64M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $98.53M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $57.35M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $58.20M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $119.83M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $87.22M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $44.67M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.18B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.89B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.96B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.25B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $3.29B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $2.30B | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | $1.86B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.24B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $945.86M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $786.90M | Feb 27, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.82B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.51B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.60B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.87B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.20B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.39B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.06B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $537.64M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $293.11M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $236.64M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.36B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.39B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.36B | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $1.38B | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $1.09B | Feb 21, 2025 |
| FY2023 | Dec 31, 2020 | $908.33M | Feb 23, 2024 |
| FY2022 | Dec 31, 2019 | $800.67M | Feb 24, 2023 |
| FY2021 | Dec 31, 2018 | $706.26M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $652.75M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $550.27M | Feb 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $622.18M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $585.77M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $589.55M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $567.06M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $543.18M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $454.73M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $351.11M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $180.17M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $124.18M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $89.20M | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.28B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.21B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.18B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.22B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $930.80M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $731.71M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $644.95M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $563.50M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $475.51M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $395.28M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $222.62M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $165.76M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $66.16M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $47.50M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $62.90M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $51.82M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $35.36M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $14.93M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $26.05M | Feb 27, 2019 |
| FY2018 | Dec 31, 2016 | $86.17M | Feb 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $945.19M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $757.25M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $847.42M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.12B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.30B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $738.25M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $630.79M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $294.12M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $49.92M | Feb 27, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 15 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 6 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 15 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 11 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 6 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 24.20M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 25.46M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 25.33M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 25.18M | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | 25.27M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 25.16M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 25.05M | Feb 26, 2021 |